Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

Z Szekanecz, MH Buch, C Charles-Schoeman… - Nature Reviews …, 2024‏ - nature.com
Janus kinase (JAK) inhibitors, including tofacitinib, baricitinib, upadacitinib and filgotinib, are
increasingly used in the treatment of rheumatoid arthritis (RA). There has been debate about …

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

M Bonelli, A Kerschbaumer, K Kastrati… - Annals of the rheumatic …, 2024‏ - Elsevier
Fundamental insight gained over the last decades led to the discovery of cytokines as
pivotal drivers of inflammatory diseases such as rheumatoid arthritis, psoriasis/psoriasis …

Pioneering a paradigm shift in asthma management: remission as a treatment goal

M Lommatzsch, R Buhl, GW Canonica… - The Lancet …, 2024‏ - thelancet.com
Until 2023, guidelines focused on asthma control as the primary goal of asthma treatment, 1
with the step-wise addition of drugs until the best possible disease control was achieved …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

JS Smolen, RBM Landewé, SA Bergstra… - Annals of the …, 2023‏ - ard.bmj.com
Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management
recommendations addressing the most recent developments in the field. Methods An …

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS …

T Frisell, H Bower, M Morin, E Baecklund… - Annals of the …, 2023‏ - ard.bmj.com
Objective Longitudinal clinical registry-infrastructures such as Anti-Rheumatic Therapies in
Sweden (ARTIS) allow simultaneous comparison of the safety of individual …

Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases

L Zeng, K Yang, G Yu, W Hao, X Zhu, A Ge… - Cell Death & …, 2024‏ - nature.com
Autoimmune diseases commonly affect various systems, but their etiology and pathogenesis
remain unclear. Currently, increasing research has highlighted the role of ferroptosis in …

[HTML][HTML] The role of marine n-3 polyunsaturated fatty acids in inflammatory-based disease: the case of rheumatoid arthritis

C Parolini - Marine Drugs, 2023‏ - mdpi.com
Inflammation is a conserved process that involves the activation of immune and non-immune
cells aimed at protecting the host from bacteria, viruses, toxins and injury. However …

Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis—Comprehensive Review

M Kciuk, A Garg, M Rohilla, R Chaudhary, S Dhankhar… - Antioxidants, 2024‏ - mdpi.com
Rheumatoid arthritis (RA) is a persistent autoimmune disorder that is characterized by joint
inflammation, discomfort, and impairment. Despite the existence of several therapeutic …

Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study

H So, TO Lam, H Meng, SHM Lam, LS Tam - Annals of the Rheumatic …, 2023‏ - Elsevier
Objectives Cardiovascular event (CVE) risk in rheumatoid arthritis (RA) was increased by
glucocorticoids (GC) use. Whether there is a threshold dose and duration of GC use beyond …

Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes

G Li, Y Fang, N Xu, Y Ding, D Liu - Arthritis Research & Therapy, 2024‏ - Springer
Background Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes
disability worldwide. Exosomes released by fibroblast-like synoviocytes in RA (RA-FLSs …